Filana Therapeutics, Inc. Operating Lease Right-of-Use Assets
Filana Therapeutics, Inc. (FLNA) had Operating Lease Right-of-Use Assets of $0 as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-02-28
- 2023-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2023-09-30: Operating Lease, Right-of-Use Asset $0.00.
- 2022-12-31: Operating Lease, Right-of-Use Asset $122.00K.
- 2022-09-30: Operating Lease, Right-of-Use Asset $144.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2022-12-31 | $122.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $144.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $166.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $188.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $210.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $231.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $252.00K 10-Q · filed 2021-08-04 |
| 2021-03-31 | $274.00K 10-Q · filed 2021-04-29 |
| 2020-12-31 | $295.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $316.00K 10-K · filed 2023-02-28 |
| 2020-06-30 | $45.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $67.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $90.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $113.00K 10-Q · filed 2019-10-29 |
| 2019-06-30 | $135.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $158.00K 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |